Phathom Pharmaceuticals, Inc.
PHATNASDAQHealthcare● Active
$9.94
$-0.19(-1.88%)
Market Cap$792757695
P/E Ratio—
52W High$18.31
52W Low$4.471
Phathom Pharmaceuticals, Inc.（PHAT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PHAT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.18B | $0.06B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.02B | $0.01B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.15B | $0.05B | $0.00B | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | 87.09% | 85.57% | 75.51% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.03B | $0.03B | $0.05B | $0.07B | $0.07B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.31B | $0.32B | $0.17B | $0.17B | $0.13B |
| Operating Income | ($0.16B) | ($0.28B) | ($0.17B) | ($0.17B) | ($0.14B) |
| Operating Margin %(computed) | -91.36% | -502.18% | — | — | — |
| Interest Income | $0.01B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.07B | $0.07B | $0.04B | $0.03B | $0.01B |
| Income Before Tax | ($0.22B) | ($0.33B) | ($0.20B) | ($0.20B) | ($0.14B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.22B) | ($0.33B) | ($0.20B) | ($0.20B) | ($0.14B) |
| Net Margin %(computed) | -126.35% | -605.09% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.03 | $-5.29 | $-3.93 | $-5.70 | $-4.00 |
| Wtd Avg Shares | 0.07B | 0.06B | 0.05B | 0.04B | 0.04B |
| EBITDA | ($0.16B) | ($0.26B) | ($0.16B) | ($0.17B) | ($0.14B) |
| EBITDA Margin %(computed) | -91.00% | -473.33% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Phathom Pharmaceuticals, Inc.
关于Phathom Pharmaceuticals, Inc.（PHAT）损益表
Phathom Pharmaceuticals, Inc.（PHAT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，PHAT实现营收$0.18B，毛利润$0.15B（毛利率87.09%），净利润($0.22B)（净利率-126.35%）。
常见问题
PHAT · 4 问Phathom Pharmaceuticals, Inc.（PHAT）2025财年营收为$0.18B，同比up216.9%。
PHAT revenuePHAT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08